Pharvaris president sells 15,000 shares at $40

Pharvaris President Lu Peng exercised stock options and sold 15,000 shares under a Rule 10b5-1 plan, with additional shares withheld to cover tax obligations.

Rhea-AI Filing Summary

Pharvaris N.V. (PHVS) reported that its President, Lu Peng, executed an options-related transaction and associated share dispositions. On September 11, 2026, Lu Peng exercised stock options to acquire 15,000 shares of common stock at an exercise price of $2.59 per share and, in connection with a cashless exercise pursuant to a Rule 10b5-1 trading plan, sold 15,000 shares at a weighted average price of $40.1298 per share, with sale prices ranging from $40.00 to $40.30.

In addition, the issuer withheld 109 shares on September 11, 2026, and 117 shares on September 14, 2026, to satisfy tax withholding obligations upon the vesting of restricted stock units. Following these transactions, Lu Peng continues to hold stock options with an exercise price of $2.59 per share for underlying 15,000 shares of common stock, expiring on February 3, 2030, with 13,308 options reported as outstanding after the exercise.

Insider Trade Summary 10b5-1

Net Seller: 15,000 shares

Net Sell 5 txns

Insider Lu Peng

Role President

Sold 15,000 shs ($602K)

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock F3	117	$38.02	$4K
Exercise	Common Stock F1	15,000	$2.59	$39K
Sale	Common Stock F1, F2	15,000	$40.1298	$602K
Tax Withholding	Common Stock F3	109	$37.51	$4K
holding	Stock Option (Right to Buy) F4	--	--	--

Holdings After Transaction: Common Stock — 64,953 shares (Direct); Stock Option (Right to Buy) — 13,308 contracts for 15,000 underlying shares (Direct)

Footnotes (4)

1. F1. This is a scheduled exercise and sale from 10b5-1 trading plan.
2. F2. The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan. The shares were sold in connection with the exercise of stock options in a cashless exercise transaction. The sales prices for the transactions ranged from $40.00 to $40.30. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
3. F3. Represents shares withheld by the issuer to satisfy tax withholding obligations upon the vesting of restricted stock units.
4. F4. 25% of the option vested on February 3, 2021 with the remaining shares vesting in 1/48 monthly installments thereafter.

Key Figures

Options exercised: 15,000 shares Option exercise price: $2.59 per share Shares sold: 15,000 shares +4 more

7 metrics

Options exercised 15,000 shares Common stock options exercised on September 11, 2026

Option exercise price $2.59 per share Exercise price for 15,000 stock options exercised on September 11, 2026

Shares sold 15,000 shares Common stock sold on September 11, 2026, in connection with cashless exercise

Weighted average sale price $40.1298 per share Weighted average for shares sold on September 11, 2026; range $40.00–$40.30

Shares withheld for taxes 226 shares Shares withheld by issuer on September 11 and 14, 2026, upon RSU vesting

Remaining option position 13,308 options Stock options outstanding after transactions, exercisable at $2.59, expiring February 3, 2030

Underlying shares on option grant 15,000 shares Underlying common shares for reported stock option position

Key Terms

Rule 10b5-1 trading plan, cashless exercise transaction, restricted stock units, weighted average sale price

4 terms

Rule 10b5-1 trading plan regulatory

"scheduled exercise and sale from 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

cashless exercise transaction financial

"shares were sold in connection with the exercise of stock options in a cashless exercise transaction"

restricted stock units financial

"tax withholding obligations upon the vesting of restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

weighted average sale price financial

"reported price represents a weighted average sale price for shares sold"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Pharvaris (PHVS) President Lu Peng report?

Lu Peng reported exercising 15,000 stock options at $2.59 per share on September 11, 2026, selling 15,000 shares at a weighted average of $40.1298 per share, and having 226 shares withheld by Pharvaris to cover tax obligations on vested restricted stock units.

Were Lu Peng’s PHVS share sales made under a Rule 10b5-1 trading plan?

Yes. The filing states the exercise and related sale of 15,000 shares were executed pursuant to a Rule 10b5-1 trading plan, and the document-level Rule 10b5-1 checkbox is marked true.

At what prices did Lu Peng sell PHVS shares in this Form 4 filing?

Lu Peng sold 15,000 shares of Pharvaris common stock at a weighted average price of $40.1298 per share. A footnote explains that individual sale prices on September 11, 2026, ranged from $40.00 to $40.30 per share.

How many PHVS shares were withheld to cover Lu Peng’s tax obligations?

The issuer withheld a total of 226 shares of Pharvaris common stock to satisfy tax withholding obligations related to restricted stock unit vesting: 109 shares on September 11, 2026, and 117 shares on September 14, 2026.

What PHVS stock options does Lu Peng still hold after these transactions?

Lu Peng is reported to hold stock options with an exercise price of $2.59 per share, expiring on February 3, 2030, covering 15,000 underlying shares of Pharvaris common stock, with 13,308 options shown as outstanding after the reported exercise.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/15/2026 - 02:30 PM Accepted by SEC EDGAR 09/15/2026 - 02:30 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lu Peng

(Last) (First) (Middle)

1 CRANBERRY HILL SUITE 400

(Street)

LEXINGTON MASSACHUSETTS 02421

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Pharvaris N.V. [ PHVS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/11/2026		M(1)		15,000	A	$2.59	80,179	D
Common Stock	09/11/2026		S(1)		15,000	D	$40.1298(2)	65,179	D
Common Stock	09/11/2026		F		109(3)	D	$37.51	65,070	D
Common Stock	09/14/2026		F		117(3)	D	$38.02	64,953	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$2.59							(4)	02/03/2030	Common Stock	15,000		13,308	D

Explanation of Responses:

1. This is a scheduled exercise and sale from 10b5-1 trading plan.

2. The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan. The shares were sold in connection with the exercise of stock options in a cashless exercise transaction. The sales prices for the transactions ranged from $40.00 to $40.30. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

3. Represents shares withheld by the issuer to satisfy tax withholding obligations upon the vesting of restricted stock units.

4. 25% of the option vested on February 3, 2021 with the remaining shares vesting in 1/48 monthly installments thereafter.

	/s/ Marnus Nel, Attorney-in-Fact for Peng Lu	09/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)